Stay updated on Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page.

Latest updates to the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.6.2 replaces the previous v3.6.0 in the page header, indicating the current page version has been updated. This reflects maintenance of the study history page rather than substantive content changes.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRecruitment status updated to no longer looking for participants, indicating enrollment has ceased. The record version is updated to v3.6.0, replacing the previous v3.5.5 revision.SummaryDifference0.3%

- Check25 days agoChange DetectedA new revision entry labeled v3.5.5 was added to the history, and the previous v3.5.4 entry was removed from the listing, reflecting an update to the record.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision entry v3.5.4 has been added to the study's record history, replacing the previous v3.5.3 entry. This reflects a minor update to the page's version metadata and does not affect study content or results.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page’s interface/version indicator updates from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a software/UI revision rather than any substantive update to the clinical trial information.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision: v3.5.2 was added to the history and Revision: v3.5.0 was removed.SummaryDifference0.1%

Stay in the know with updates to Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page.